BIA webinar recording: UK Leadership in AMR - driving international collaboration and new economic models
Watch the recording of the BIA UK Leadership in AMR webinar focused on driving international collaboration and new economic models.
Antimicrobial resistance (AMR) is an urgent global health threat. A study published in the Lancet in January estimated that in 2019, over one million people died from drug-resistant infections directly attributable to AMR.
Over the past year, the UK has played a key role in driving forward efforts to tackle AMR, including through the launch of its pilot project for an innovative subscription-style payment model for antimicrobials. The UK has also supported international efforts to increase funding for novel antimicrobials and promote stewardship in their use.
Chaired by Deborah O’Neil, CEO of NovaBiotics and BIA Board Member, an expert panel of speakers discuss the progress that has been made and the challenges that lie ahead.